Taken together, these results show that despite CD4+/FoxP3+ cells making up a large portion of tumor infiltrating lymphocytes within the TIME of our UZA cohort, the presence of intratumoral cytotoxic lymphocytes such as CD8+ T cells and NKp46+ NK cells was overall much stronger and results in a better patient outcome. The gene discussed is CD8A; the disease is neoplasm.